When services can be administered in various settings, the Company reserves the right to reimburse only those services that are furnished in the most appropriate and cost-effective setting that is appropriate to the member’s medical needs and condition. This decision is based on the member’s current medical condition and any required monitoring or additional services that may coincide with the delivery of this service.
This Medical Policy Bulletin document describes the status of medical technology at the time the document was developed. Since that time, new technology may have emerged or new medical literature may have been published. This Medical Policy Bulletin will be reviewed regularly and be updated as scientific and medical literature becomes available. For more information on how Medical Policy Bulletins are developed, go to the About This Site section of this Medical Policy Web site.
Binkley N, Krueger D, Gangnon R et al. Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures. Osteoporos Int. 2005; 16(12):1513-8.
Blue Cross Blue Shield Association (BCBSA) Technology Evaluation Center. Screening for vertebral fracture with dual x-ray absorptiometry [technology assessment]. Assessment Program Volume 20, No. 14. February 2006. [BCBSA Web site].
Centre for Metabolic Bone Diseases, University of Sheffield U. FRAX Fracture Risk Assessment Tool: Calculation Tool. n.d. Available online at: https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9. Accessed January 19, 2020.
Cosman F, de Beur SJ, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporosis Int. 2014;25(8). Available at: https://cdn.nof.org/wp-content/uploads/2016/01/995.pdf. Accessed at January 10, 2018.
Cummings SR, Black DM, Thompson DE et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998; 280(24):2077-82.
Diacinti D, Del Fiacco R, Pisani D et al. Diagnostic Performance of Vertebral Fracture Assessment by the Lunar iDXA Scanner Compared to Conventional Radiography. Calcif Tissue Int. 2012; 91(5):335-42.
Diacinti D, Guglielmi G, Pisani D et al. Vertebral morphometry by dual-energy X-ray absorptiometry (DXA) for osteoporotic vertebral fractures assessment (VFA). Radiol Med. 2012; 117(8):1374-85.
Domiciano DS, Figueiredo CP, Lopes JB et al. Vertebral fracture assessment by dual X-ray absorptiometry: a valid tool to detect vertebral fractures in community-dwelling older adults in a population-based survey. Arthritis Care Res. 2013; 65(5):809-15.
Eastell R, Rosen CJ, Black DM, et al. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1595-1622. Available at: https://academic.oup.com/jcem/article/104/5/1595/5418884. Accessed January 16, 2020.
Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282(7):637-45.
Ferrar L, Jiang G, Barrington NA, Eastell R. Identification of vertebral deformities in women: Comparison of radiological assessment and quantitative morphometry using morphometric radiography and morphometric X-ray absorptiometry. J Bone Miner Res. 2000;15(3):575-85.
Ferrar L, Jiang G, Clowes J et al. Comparison of densitometric and radiographic vertebral fracture assessment using the algorithm-based qualitative (ABQ) method in postmenopausal women at low and high risk of fracture. J Bone Miner Res. 2007; 23(1):103-11.
Ferrar L, Jiang G, Eastell R, Peel NF. Visual identification of vertebral fractures in osteoporosis using morphometric X-ray absorptiometry. J Bone Miner Res. 2003;18(5):933-8.
Greenspan SL, Nelson JB, Trump DL et al. Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer. Ann Intern Med. 2007; 146(6):416-24.
Greenspan SL, von Stetten E, Emond SK, et al. Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. J Clin Densitom. 2001;4(4):373-380.
Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282(14):1344-52.
International Society for Clinical Densitometry. 2019 ISCD Official Position – Adult. Available at: https://www.iscd.org/official-positions/2019-iscd-official-positions-adult/. Accessed January 16, 2020.
Jager PL, Jonkman S, Koolhaas W et al. Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations. Osteoporos Int. 2011; 22(4):1059-68.
Kanis JA, Barton IP, Johnell O. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int. 2005; 16(5):475-82.
Kanterewicz E, Puigoriol E, Garcia-Barrionuevo J et al. Prevalence of vertebral fractures and minor vertebral deformities evaluated by DXA-assisted vertebral fracture assessment (VFA) in a population-based study of postmenopausal women: the FRODOS study. Osteoporos Int. 2014; 25(5):1455-64.
Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333(22):1437-1443.
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Available online at: http://www.menopause.org/docs/default-document-library/psosteo10.pdf?sfvrsn=2
Accessed January 10, 2018.
Mrgan M, Mohammed A, Gram J. Combined Vertebral Assessment and Bone Densitometry Increases the Prevalence and Severity of Osteoporosis in Patients Referred to DXA Scanning. J Clin Densitom. 2013; 16(4):549-53.
National Osteoporosis Foundation (NOF). Physician's Guide to Prevention and Treatment of Osteoporosis; 2003 updated in2009.
Quandt SA, Thompson DE, Schneider DL et al. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of -1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc. 2005; 80(3):343-9.
Rea JA, Li J, Blake GM, et al. Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformity. Osteoporos Int. 2000;11(8):660-8.
Rea JA, Chen MB, Li J, et al. Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of prevalent vertebral deformity identification. J Bone Miner Res. 2000;15(3):564-74.
Schousboe JT, DeBold CR, Bowles C, et al. Prevalence of vertebral compression fracture deformity by X-ray absorptiometry of lateral thoracic and lumbar spines in a population referred for bone densitometry. J Clin Densitom. 2002;5(3):239-46.
US Food and Drug Administration (FDA). Center for Devices and Radiological Health. GE Dual-Energy Vertebral Assessment View Software Option [510(k) market approval]. [FDA Web site]. 12/20/2002. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf2/K023554.pdf. Accessed January 10, 2018.
US Food and Drug Administration (FDA). Center for Devices and Radiological Health. IVA (MXA-II) software option for the X-Ray bone densitometers [510(k) market approval]. [FDA Web site]. 04/24/2006. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf6/K060111.pdf. Accessed January 10, 2018.
US Preventive Services Task Force. Osteoporosis to Prevent Fractures: Screening. 2018. Available at:https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/osteoporosis-screening1. Accessed January 16, 2020.
Vestergaard P. Anti-resorptive therapy for the prevention of postmenopausal osteoporosis: When should treatment begin? Treat Endocrinol. 2005;4(5):263-77.
Vokes TJ, Dixon LB, Favus MJ. Clinical utility of dual-energy vertebral assessment (DVA). Osteoporos Int. 2003;14(11):871-8.